Evidence map›Paper›PMID 36790464›Full record

ArticleArchives of gynecology and obstetrics2023

The use of sealing hemostat patch (HEMOPATCH

Roberto Montera, Fernando Ficarola, Francesco Plotti, Corrado Terranova, Carlo De Cicco Nardone, Federica Guzzo, Roberto Angioli, Daniela Luvero

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Roberto MonteraCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Fernando FicarolaCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy. f.ficarola@unicampus.it.ORCID 0000-0002-2474-2442
Francesco PlottiCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Corrado TerranovaCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Carlo De Cicco NardoneCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Federica GuzzoCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Roberto AngioliCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Daniela LuveroCampus Bio-Medico University Hospital Foundation, Department of Obstetrics and Gynecology, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Università Campus Bio-Medico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUterine myomas are the most common gynecological disease. In these cases, a myomectomy is performed traditionally laparotomically. However, alternatives have been widely used, including laparoscopic, endoscopic, and robotic surgery. During these techniques, diffuse parenchymatous bleeding remains one of the main intraoperative and postoperative complications and sometimes requires unplanned hysterectomies. Recently, hemostatic agents and sealants have been used to prevent excessive blood loss during surgical repair.

methodsWe propose a prospective case-control study on the use of a sealing hemostat patch (HEMOPATCH

resultsIn group A, we achieve faster hemostasis (p < 0.05), than in group B. We report a significantly lower C-reactive protein value on the second and third days after surgery for group A compared to group B.

conclusionsHEMOPATCH

Indexed as

HemostaticsLaparoscopyLeiomyomaUterine MyomectomyUterine NeoplasmsBlood Loss, SurgicalCase-Control StudiesFemaleHumansHemostaticsHEMOPATCH®Hemostasis timeHemostatic agentsLaparotomic myomectomySealing hemostat patch

Identifiers

PMID36790464
OpenAlexW4320856078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.